Adam RosenthalTop StoriesPersonalized medicineSanofi to Acquire Provention BioThe transaction will add Tzield, the first disease-modifying treatment for the delay of Stage 3 type 1 diabetes, to Sanofi’s portfolio.Automation/RoboticsRobots Stand Out in an Automated FutureAdherence/DeliveryHuman Factors Projects—Quick Wins and Practical TipsTraceability/SerializationAntares Vision Group Partnering With Renown Health NetworkPMMI newsEmerging Brands Alliance Announces 2023 Grant Program
